"Thousand of patients left in agony by faulty hip replacement" - The Independent, 12th September 2010
Francis Hanna & Company are now advising patients throughout Ireland who have been fitted with a DePuy ASR hip implant, either during hip replacement or hip resurfacing and who are experiencing problems to seek compensation. Many of these individuals have required further surgery for revision, or are expected to require revision in the future. These individuals will also be eligible to apply for compensation against the manufacturer for the injuries suffered and for any financial losses incurred caused by the defective product.
Since the product was launched in 2003, over 10,000 people in the UK and Ireland have been fitted with a DePuy ASR hip implant, either during hip replacement or hip resurfacing. Towards the end of 2009 experts in Australia became concerned that a large number of ASR hips were failing prematurely, often requiring further surgery.
Earlier this year, the UK Medicines and Healthcare Products Regulatory Authority (MHRA) issued a notice about the ASR hip, saying that there may be a problem. They began their own investigations.
In September 2010, the manufacturer, DePuy, decided that the products should no longer be used; that unused stock should be returned to the manufacturer; and patients who had received an ASR device should be checked by their surgeons and, if they showed symptoms of failure of the device, revision surgery should be considered.
While the revision rate is still relatively low, at about 12% or 13% within five years, this is more than twice the rate that would be expected from other hip products. It is therefore expected that a very large number of patients will have hip pain and will require additional surgery due to the defect in the particular hip used. In many cases, such patients will be entitled to compensation from DePuy.